|
References
1. What are the risk factors for cervical cancer? American Cancer Society. Available at: www.cancer.org/docroot/CRI/content/CRI_2_4_2X_What_are_the_risk_factors_for_cervical_cancer_8.asp. Last accessed Mar. 20, 2008.
2. Cervical cancer. National Cancer Institute. Available at: www.cancer.gov/cancertopics/types/cervical. Last accessed Mar. 20, 2008.
3. U.S. Cancer Statistics Working Group.
United States
Cancer Statistics: 2003 Incidence and Mortality.
Atlanta, Ga
: US Dept of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2006. Available at: www.cdc.gov/cancer/npcr/npcrpdfs/US_Cancer_Statistics_2003_Incidence_and_Mortality.pdf. Last accessed Mar. 20, 2008.
4. Screening for cervical cancer. In: Guide to Clinical Preventive Services, 2005: Recommendations of the
U.S.
Preventive Services Task Force.
Rockville, MD: Agency for Healthcare Research and Quality. Available at: www.ahrq.gov/clinic/pocketgd05/gcps2.htm#Cervical. Last accessed Mar. 20, 2008.
5. Screening for cervical cancer. Canadian Task Force on Preventive Health Care. Available at: www.ctfphc.org/Full_Text/Ch73full.htm. Last accessed Mar. 20, 2008.
6. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes. Br Med J (Clin Res Ed). 1986;293:659-664.
7. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med. 2000;132:810-819.
8. O'Leary TJ, Tellado M, Buckner SB, Ali IS, Stevens A, Ollayos CW. PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100 percent manual rescreening strategy. JAMA. 1998;279:235-237.
9. Buntinx F, Brouwers M. Relation between sampling device and detection of abnormality in cervical smears: a meta-nalysis of randomised and quasi-randomised studies. BMJ. 1996:313:1285-1290.
10. Karnon J, Peters J, Platt J, et al. Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. Health Technol Assess. 2004;8:1-78.
11. Melnikow J, Nuovo J. Reducing mortality due to cervical cancer: PAPNET fails the test. Ann Intern Med. 1999;8:56-57.
12. Stewart RA, Thistlewaite J. Routine pelvic examination for asymptomatic women-exploring the evidence. Aust Fam Physician. 2006;35:873-877.
13. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
14. Waller J, McCaffery K, Forrest S, et al. Awareness of human papillomavirus among women attending a well woman clinic. Sex Transm Infect. 2003;79:320-322.
15. Gottlieb N. A primer on HPV. BenchMarks. April 24, 2002;2(4):2. Available at: www.cancer.gov/newscenter/benchmarks-vol2-issue4/page2. Last accessed Mar. 20, 2008.
16. Harper DM, Longacre MR, Noll WW, et al. Factors affecting the detection rate of human papillomavirus. Ann Fam Med. 2003;1:221-227.
17. Philips Z, Johnson S, Avis M, Whynes DK. Human papillomavirus and the value of screening: young women's knowledge of cervical cancer. Health Educ Res. 2003;18:318-328.
18. Vernick JP, Steigman CK. The HPV DNA virus hybrid capture assay: what is it-and where do we go from here? MLO Med Lab Obs. 2003;35:8-15.
19. Nieminen P, Vuorma S, Viikki M, et al. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. BJOG. 2004;111:842-848.
20. Wright TC Jr, Cox JT, Massad LS, et al. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120-2129.
21. Cervical Cancer: Screening Recommendations, With Algorithms, for Managing Women With Abnormal Pap Test Results.
Boston
, Mass: Brigham and Women's Hospital; December 2004:1-11.
22. Brief summary. National Guideline Clearinghouse. Available at: www.guideline.gov/summary/summary.aspx?doc_id=7011&nbr=4220. Last accessed Mar. 20, 2008.
23. Sirovich BE, Welch HG. Cervical cancer screening among women without a cervix. JAMA. 2004;291:2990-2993.
24. Sirovich BE, Welch HG. The frequency of Pap smear screening in the
United States
. J Gen Intern Med. 2004;19:243-250.
25. Sawaya GF, Kerlikowske K, Lee NC, et al. Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol. 2000;96:219-223.
26. Lawson HW, Henson R, Bobo JK, et al. Implementing recommendations forthe early detection of breast and cervical cancer among low-income women. MMWR Recomm Rep. 2000;49:37-55.
|